Cargando…
Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device: Phase 2 Data to 36 Months
To assess in parous and nulliparous women, the efficacy, safety, and tolerability of a new, low-dose copper (175 mm(2)) intrauterine contraceptive with a flexible nitinol frame provided in a preloaded applicator. METHODS: Institutional review boards at 12 U.S. sites approved this commercially funded...
Autores principales: | Turok, David K., Nelson, Anita L., Dart, Clint, Schreiber, Courtney A., Peters, Kevin, Schreifels, Mary Jo, Katz, Bob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098438/ https://www.ncbi.nlm.nih.gov/pubmed/32168217 http://dx.doi.org/10.1097/AOG.0000000000003756 |
Ejemplares similares
-
Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception
por: BakenRa, Abena, et al.
Publicado: (2021) -
Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019) -
Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users
por: Spotnitz, Matthew E., et al.
Publicado: (2020) -
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion
por: Anthony, Mary S., et al.
Publicado: (2022) -
Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage
por: D’Alton, Mary E., et al.
Publicado: (2020)